American College of Cardiology

Twelve Must-Have Apps for Healthcare ExecutivesWe asked the Managed Healthcare Executive board to share their favorite app—for work or for play. Here’s what they said.
Six barriers to prescribing PCSK9 inhibitorsA National Lipid Association survey has interesting findings on the prescription approval process for PCSK9 inhibitors.
Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.
Statin prescribing varies in patients with diabetesWide variation exists in practice-level statin prescribing for patients with diabetes, according to a new study.
Entresto may prevent death in some heart failure patientsTimely and broad use of Entresto could prevent or postpone more than 28,000 US deaths per year among HFrEF patients, according to research in JAMA Cardiology.
Novartis signs on to value-based pricing for EntrestoHospitalizations represent up to 80 percent of the direct medical costs of heart failure; reducing heart failure hospitalizations can help bring down overall healthcare costs.
First-ever guide for echocardiography in kidsThe American College of Cardiology has published the first appropriate use criteria for initial outpatient transthoracic echocardiography to evaluate children with possible heart disease.
New screening guide for congenital heart diseaseThe American Heart Association and the American College of Cardiology have jointly issued a new scientific statement on screening for congenital and genetic heart conditions that can lead to rare sudden death in young persons aged 12 to 25 years.
CDC expert questions statin use for more AmericansLast November, the American Heart Association (AHA) and the American College of Cardiology (ACC) recommended statin therapy for approximately 33 million more Americans who don’t have cardiovascular disease (CVD), but have an estimated 10-year CV risk of 7.5% or higher.
Value now a component in development of guidelines and performance measures
Value now a component in development of guidelines and performance measuresRecognizing the rising cost of healthcare and the importance of providing value to patients, resource utilization and value assessments will now be explicitly considered in the development of clinical practice guidelines and performance measures from the American College of Cardiology/American Heart Association.